High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia

Genes and Development

Volumn 19, Issue 2, 2005, Pages 224-233

  Bijl, Janet ^a   Sauvageau, Martin ^a   Thompson, Alexander ^a,b   Sauvageau, Guy ^a,c,d  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

B cell leukemia model; E2a PBX; Homeobox; Oncogenic collaborators; Transgenics

Indexed keywords

PROTEIN; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; CONTROLLED STUDY; GENE; GENE CLUSTER; GENE CONTROL; GENE LOCUS; GENE OVEREXPRESSION; HOXA GENE; HOXA10 GENE; HOXA6 GENE; MOUSE; MUTAGENESIS; NONHUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; TRANSGENIC MOUSE; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; ANTIGENS, CD3; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, LEUKEMIC; HOMEODOMAIN PROTEINS; LEUKEMIA, PRE-B-CELL; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; ONCOGENE PROTEINS, FUSION; QUANTITATIVE TRAIT LOCI; T-LYMPHOCYTES; TRANS-ACTIVATORS; VIRUS INTEGRATION;

ANIMALIA; MUS MUSCULUS;

EID: 12144252423     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1268505     Document Type: Article

References (38)

1. Berns, A., Mikkers, H., Krimpenfort, P., Allen, J., Scheijen, B., and Jonkers, J. 1999. Identification and characterization of collaborating oncogenes in compound mutant mice. Cancer Res. 59: 1773s-1777s.
2. Carroll, A.J., Crist, W.B., Parmley, R.T., Roper, M., Cooper, M.D., and Finley, W.H. 1984. Pre-B cell leukemia associated with chromosome translocation 1;19. Blood 63: 721-724.
3. Dedera, D.A., Waller, E.K., LeBrun, D.P., Sen-Majumdar, A., Stevens, M.E., Barsh, G.S., and Cleary, M.L. 1993. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell 74: 833-843.
4. Feldman, B.J., Hampton, T., and Cleary, M.L. 2000. A carboxyterminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice. Blood 96: 1906-1913.
5. Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D., and Hayakawa, K. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173: 1213-1225.
6. Herblot, S., Aplan, P.D., and Hoang, T. 2002. Gradient of E2A activity in B-cell development. Mol. Cell. Biol. 22: 886-900.
7. Hough, M.R., Takei, F., Humphries, R.K., and Kay, R. 1994. Defective development of thymocytes overexpressing the costimulatory molecule, heat-stable antigen. J. Exp. Med. 179: 177-184.
8. Joosten, M., Vankan-Berkhoudt, Y., Tas, M., Lunghi, M., Jenniskens, Y., Parganas, E., Valk, P.J., Lowenberg, B., van den, A.E., and Delwel, R. 2002. Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites. Oncogene 21: 7247-7255.
9. Kamps, M.P. and Baltimore, D. 1993. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol. Cell. Biol. 13: 351-357.
10. Kamps, M.P. and Wright, D.D. 1994. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. Oncogene 9: 3159-3166.
11. Kamps, M.P., Murre, C., Sun, X.H., and Baltimore, D. 1990. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60: 547-555.
12. Kamps, M.P., Wright, D.D., and Lu, Q. 1996. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation. Oncogene 12: 19-30.
13. Kee, B.L., Cumano, A., Iscove, N.N., and Paige, C.J. 1994. Stromal cell independent growth of bipotent B cell-Macrophage precursors from murine fetal liver. Int. Immunol. 6: 401-407.
14. Knoepfler, P.S., Sykes, D.B., Pasillas, M., and Kamps, M.P. 2001. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation. Oncogene 20: 5440-5448.
15. Kroon, E., Krosl, J., Thorsteinsdottir, U., Baban, S., Buchberg, A.M., and Sauvageau, G. 1998. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meisla but not Pbx1b. EMBO J. 17: 3714-3725.
16. Krosl, J. and Sauvageau, G. 2000. AP-1 complex is effector of Hox-induced cellular proliferation and transformation. Oncogene 19: 5134-5141.
17. Lessard, J. and Sauvageau, G. 2003. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423: 255-260.
18. Lessard, J., Baban, S., and Sauvageau, G. 1998. Stage-specific expression of Polycomb group genes in human bone marrow cells. Blood 91: 1216-1224.
19. Lessard, J., Schumacher, A., Thorsteinsdottir, U., van Lohuizen, M., Magnuson, T., and Sauvageau, G. 1999. Functional antagonism of the Polycomb-group genes eed and Bmi1 in hemopoietic cell proliferation. Genes & Dev. 13: 2691-2703.
20. Look, A.T. 1997. Oncogenic transcription factors in the human acute leukemias. Science 278: 1059-1064.
21. Lu, Q., Knoepfler, P.S., Scheele, J., Wright, D.D., and Kamps, M.P. 1995. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes. Mol. Cell. Biol. 15: 3786-3795.
22. Malissen, M., Gillet, A., Ardouin, L., Bouvier, G., Trucy, J., Ferrier, P., Vivier, E., and Malissen, B. 1995. Altered T cell development in mice with a targeted mutation of the CD3-ε gene. EMBO J. 14: 4641-4653.
23. Mikkers, H., Allen, J., Knipscheer, P., Romeijn, L., Hart, A., Vink, E., Berns, A., and Romeyn, L. 2002. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat. Genet. 32: 153-159.
24. Monica, K., LeBrun, D.P., Dedera, D.A., Brown, R., and Cleary, M.L. 1994. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: Fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol. Cell. Biol. 14: 8304-8314.
25. Nakamura, T., Largaespada, D.A., Lee, M.P., Johnson, L.A., Ohyashiki, K., Toyama, K., Chen, S.J., Willman, C.L., Chen, I.M., Feinberg, A.P., et al. 1996. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat. Genet. 12: 154-158.
26. Nourse, J., Mellentin, J.D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S.D., and Cleary, M.L. 1990. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60: 535-545.
27. Penkov, D., Tanaka, S., Di Rocco, G., Berthelsen, J., Blasi, F., and Ramirez, F. 2000. Cooperative interactions between PBX, PREP, and HOX proteins modulate the activity of the α 2(V) collagen (COL5A2) promoter. J. Biol. Chem. 275: 16681-16689.
28. Rabbitts, T.H. 1994. Chromosomal translocations in human cancer. Nature 372: 143-149.
29. Sauvageau, G., Lansdorp, P.M., Eaves, C.J., Hogge, D.E., Dragowska, W.H., Reid, D.S., Largman, C., Lawrence, J.H., and Humphries, R.K. 1994. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc. Natl. Acad. Sci. 91: 12223-12227.
30. Schnabel, C.A., Jacobs, Y., and Cleary, M.L. 2000. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene 19: 608-616.
31. Suzuki, T., Shen, H., Akagi, K., Morse, H.C., Malley, J.D., Naiman, D.Q., Jenkins, N.A., and Copeland, N.G. 2002. New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32: 166-174.
32. Sykes, D.B. and Kamps, M.P. 2004. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice. Mol. Cell. Biol. 24: 1256-1269.
33. Thompson, A., Quinn, M.F., Grimwade, D., O'Neill, C.M., Ahmed, M.R., Grimes, S., McMullin, M.F., Cotter, F., and Lappin, T.R. 2003. Global down-regulation of HOX gene expression in PML-RARα + acute promyelocytic leukemia identified by small-array real-time PCR. Blood 101: 1558-1565.
34. Thorsteinsdottir, U., Sauvageau, G., Hough, M.R., Dragowska, W., Lansdorp, P.M., Lawrence, H.J., Largman, C., and Humphries, R.K. 1997. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol. Cell. Biol. 17: 495-505.
35. Thorsteinsdottir, U., Krosl, J., Kroon, E., Haman, A., Hoang, T., and Sauvageau, G. 1999. The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells. Mol. Cell. Biol. 19: 6355-6366.
36. van Lohuizen, M., Verbeek, S., Scheijen, B., Wientjens, E., van der, G.H., and Berns, A. 1991. Identification of cooperating oncogenes in E μ-myc transgenic mice by provirus tagging. Cell 65: 737-752.
37. Whitlock, C.A. and Witte, O.N. 1987. Long-term culture of murine bone marrow precursors of B lymphocytes. Methods Enzymol. 150: 275-286.
38. Williams, D.L., Look, A.T., Melvin, S.L., Roberson, P.K., Dahl, G., Flake, T., and Stass, S. 1984. New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell 36: 101-109.